Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 426 across all filing types
Latest filing 2026-03-16 Proxy Solicitation & In…
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items (such as approval of financial statements and director appointments), and proxy voting procedures. While it includes financial data, this is provided as reference material for the shareholders to make informed voting decisions, not as the Annual Report itself. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '에이비프로바이오'. It details the meeting date, location, agenda items (such as approval of financial statements, election of directors, and auditor appointments), and provides biographical details for the nominees. This type of document is a standard proxy solicitation material sent to shareholders to inform them of upcoming meeting agendas and to request their votes, which falls under the Proxy Solicitation & Information Statement category.
2026-03-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This document details the terms of the financing, including interest rates, conversion prices, and the use of proceeds. In the context of corporate filings, this falls under capital structure changes and financing activities, which is classified as 'CAP'.
2026-03-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This is a regulatory disclosure regarding capital structure changes and financing activities. According to the provided filing categories, documents detailing fundraising, financing activities, or capital structure changes are classified as 'CAP'.
2026-03-16 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from ABProBio regarding a decision for a third-party paid-in capital increase (유상증자결정). This document details the issuance of new shares, the purpose of the capital raise, the allocation to a third party (㈜리턴즈), and the impact on the company's share structure. In the context of financial filings, announcements regarding the issuance of new shares, capital increases, or changes in capital structure are classified as 'Share Issue/Capital Change'.
2026-03-16 Korean
경영권변경등에관한계약체결
M&A Activity Classification · 95% confidence The document is a regulatory filing regarding a 'Change in Management Control' (경영권 변경 등에 관한 계약 체결) involving a share issuance and transfer of control. This type of corporate action, specifically involving M&A-related control changes and share issuance, falls under the category of M&A Activity (TAR) as it details the contractual agreement for the transfer of management control between the parties.
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.